Top Markets
Coin of the day
IGEA Pharma N.V. IGEA Pharma N.V.

IGEA Pharma N.V.

IGPH
Rank in Stocks #40706
IGEA Pharma N.V. specializes in marketing health and medical technology... IGEA Pharma N.V. specializes in marketing health and medical technology products and devices across the United States and the Netherlands. Its product portfolio features Alz1, a home-based diagnostic kit for measuring non-bound copper in the bloodstream, alongside Alz1 Tab dietary supplements formulated to decrease heavy metal levels in the blood. The company also offers a rapid test for COVID-19, which identifies IgM and IgG SARS-CoV-2 antibodies. Additionally, it provides dry aerosol generators for sanitizing air and inanimate surfaces, as well as equipment for air purification and sterilization. The company also performs laboratory analysis services. Founded in 2015, IGEA Pharma N.V. maintains its primary offices in Hoofddorp, the Netherlands.
Share Price
$0.00057292
Last synced: 2023-12-04
Market Cap
$95.08K
Change (1 day)
0.59%
Change (1 year)
0.00%
Country
NL
Trade IGEA Pharma N.V. (IGPH)

Category

P/E ratio for IGEA Pharma N.V. (IGPH)
P/E ratio as of 2026 TTM: 0
According to IGEA Pharma N.V. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for IGEA Pharma N.V. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
30.84 -
US
34.53 -
US
- -
CN
-164.27 -
US
40.90 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.